​

Corbus Pharmaceuticals Ownership | Who Owns Corbus Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Corbus Pharmaceuticals Ownership Summary

100.00% retail investors. SPDR® S&P Biotech ETF is the top mutual fund, with 3.05% of its assets in Corbus Pharmaceuticals shares.

CRBP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorbus Pharmaceuticals--100.00%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20231-98.41%100-100.00%-0.00%--100.00%1-93.75%
Dec 31, 2022635.00%11,889,537-49.17%92.72%2327.78%1614.29%
Sep 30, 202260-9.09%23,391,533-26.54%182.89%18-33.33%14-
Jun 30, 202266-8.33%31,842,077-15.02%252.84%273.85%14-36.36%
Mar 31, 202272-12.20%37,471,809-15.87%292.28%26-25.71%2210.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
SPDR® S&P Biotech ETF371.62K3.05%5.29K
Vanguard Total Stock Mkt Idx Inv362.22K2.97%-
HBM Healthcare Investments AG Ord320.00K2.66%320.00K
iShares Russell 2000 ETF318.86K2.62%-1.23K
Biotech Growth Ord266.30K2.19%266.30K
Vanguard Institutional Extnd Mkt Idx Tr174.43K1.43%-
Global X Marijuana Life Sciences ETF160.79K1.32%-2.71K
Fidelity Small Cap Index105.15K0.86%-75.00
Nuveen Quant Small Cap Equity R698.90K0.82%-
HealthInvest Sustainable Healthcare E70.64K0.58%17.57K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 20, 2024Cormorant Asset Management, LP-Buy$1.02M
Sep 20, 2024Cormorant Asset Management, LP-Buy$2.85M
Sep 20, 2024Cormorant Asset Management, LP-Buy$1.30M
Sep 20, 2024Cormorant Asset Management, LP-Buy$476.31K
Sep 20, 2024Cormorant Asset Management, LP-Buy$572.79K

Insider Transactions Trends

DateBuySell
2024 Q2-7
2024 Q125-
2023 Q2--
2023 Q1--
2022 Q33-

CRBP Ownership FAQ

Who Owns Corbus Pharmaceuticals?

Corbus Pharmaceuticals shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Corbus Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Corbus Pharmaceuticals falls below.

Does Blackrock own Corbus Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Corbus Pharmaceuticals.

Who is the top mutual fund holder of Corbus Pharmaceuticals shares?

SPDR® S&P Biotech ETF is the top mutual fund holder of Corbus Pharmaceuticals shares, with 3.05% of its total shares outstanding invested in 371.62K Corbus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools